EPA and DHA containing phospholipids have contrasting effects on membrane structure

Kinetics of generic tacrolimus in heart transplantation: A cautionary note

Mechanistic insights from REDUCE-IT STRENGTHen the case against triglyceride lowering as a strategy for cardiovascular disease risk reduction

Icosapent ethyl reduces ischemic events in patients with high triglycerides and low high-density lipoprotein cholesterol levels: REDUCE-IT high TC/low HDL-C analyses

Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid

Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro

Double-blind RCT of fish oil supplementation in pregnancy and lactation to improve the metabolic health in children of mothers with overweight or obesity during pregnancy: study protocol

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management